A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer

M. E. McDowell, Stefano Occhipinti, R. A. Gardiner, P. D. Baade, S. K. Steginga

Research output: Journal article publicationReview articleAcademic researchpeer-review

25 Citations (Scopus)

Abstract

First-degree relatives of men with prostate cancer have a higher risk of being diagnosed with prostate cancer than men without a family history. The present review examines the prevalence and predictors of testing in first-degree relatives, perceptions of risk, prostate cancer knowledge and psychological consequences of screening. Medline, PsycInfo and Cinahl databases were searched for articles examining risk perceptions or screening practices of first-degree relatives of men with prostate cancer for the period of 1990 to August 2007. Eighteen studies were eligible for inclusion. First-degree relatives participated in prostate-specific antigen (PSA) testing more and perceived their risk of prostate cancer to be higher than men without a family history. Family history factors (e.g. being an unaffected son rather than an unaffected brother) were consistent predictors of PSA testing. Studies were characterized by sampling biases and a lack of longitudinal assessments. Prospective, longitudinal assessments with well-validated and comprehensive measures are needed to identify factors that cue the uptake of screening and from this develop an evidence base for decision support. Men with a family history may benefit from targeted communication about the risks and benefits of prostate cancer testing that responds to the implications of their heightened risk.

Original languageEnglish
Pages (from-to)545-555
Number of pages11
JournalEuropean Journal of Cancer Care
Volume18
Issue number6
DOIs
Publication statusPublished - Nov 2009

Keywords

  • Family history
  • Prostate cancer
  • Review
  • Screening

ASJC Scopus subject areas

  • Oncology

Fingerprint

Dive into the research topics of 'A review of prostate-specific antigen screening prevalence and risk perceptions for first-degree relatives of men with prostate cancer'. Together they form a unique fingerprint.

Cite this